Home
Home

Par Pharmaceutical

FDA approves Par Pharma fluvoxamine maleate ER capsules ANDA

FDA approves Par Pharma fluvoxamine maleate ER capsules ANDA
Pharmaceutical Business Review

Par to pay $45M for off-label Megace marketing

Par to pay $45M for off-label Megace marketing
Fierce Pharma

Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug

Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug
Bloomberg

United States : White & Case Secures Victory in AndroGel Antitrust Class Actions [TendersInfo (India)]

United States : White & Case Secures Victory in AndroGel Antitrust Class Actions
equities.com

No more bids for Par Pharma, so $1.9B deal with TPG stands

No more bids for Par Pharma, so $1.9B deal with TPG stands
Fierce Pharma

Somaxon settles Silenor litigation with Mylan and PAR

Somaxon settles Silenor litigation with Mylan and PAR
Yahoo

Par Pharmaceutical agrees to be acquired by TPG affiliate for about $1.84 billion in cash

Par Pharmaceutical agrees to be acquired by TPG affiliate for about $1.84 billion in cash
Washington Post, DC

The $150 Million Patent

The $150 Million Patent
Motley Fool

The Tale of 2 Patents

The Tale of 2 Patents
Motley Fool

Teva selling generic version of Provigil; says Par will start selling its own generic Friday

Teva selling generic version of Provigil; says Par will start selling its own generic Friday
Yahoo/AP